Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease
复制标题
DOI:
10.1007/s10875-024-01660-6
复制
发表时间:
2024-02
影响因子:
9.1
通讯作者:
Clémence David;Mihaly Badonyi;Robin Kechiche;Antonella Insalaco;M. Zecca;Fabrizio de Benedetti
中科院分区:
文献类型:
--
作者:
Clémence David;Mihaly Badonyi;Robin Kechiche;Antonella Insalaco;M. Zecca;Fabrizio de Benedetti
TLR7 recognizes pathogen-derived single-stranded RNA (ssRNA), a function integral to the innate immune response to viral infection. Notably, TLR7 can also recognize self-derived ssRNA, with gain-of-function mutations in human TLR7 recently identified to cause both early-onset systemic lupus erythematosus (SLE) and neuromyelitis optica. Here, we describe two novel mutations in TLR7, F507S and L528I. While the L528I substitution arose de novo, the F507S mutation was present in three individuals from the same family, including a severely affected male, notably given that the TLR7 gene is situated on the X chromosome and that all other cases so far described have been female. The observation of mutations at residues 507 and 528 of TLR7 indicates the importance of the TLR7 dimerization interface in maintaining immune homeostasis, where we predict that altered homo-dimerization enhances TLR7 signaling. Finally, while mutations in TLR7 can result in SLE-like disease, our data suggest a broader phenotypic spectrum associated with TLR7 gain-of-function, including significant neurological involvement.